Ignite Creation Date:
2025-12-25 @ 1:30 AM
Ignite Modification Date:
2026-02-24 @ 4:11 AM
Study NCT ID:
NCT02805894
Status:
TERMINATED
Last Update Posted:
2021-05-10
First Post:
2016-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
Sponsor:
Nanobiotix
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NBTXR3-104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None